Status:
ACTIVE_NOT_RECRUITING
ISCHEMIA-EXTEND (Extended Follow-up)
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
New York University
Stanford University
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
All Genders
21+ years
Brief Summary
The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Extended Follow-up (ISCHEMIA-EXTEND) is the long-term follow-up of randomized, surviving par...
Detailed Description
The primary goals of all therapies are to enable patients to feel better and/or live longer. ISCHEMIA provided definitive data on the benefit of INV on quality of life. However, mortality is the most ...
Eligibility Criteria
Inclusion
- Alive at the end of the initial follow-up period for ISCHEMIA
Exclusion
- Participants who withdrew consent during initial trial phase
- Participants who declined participation in long-term follow-up
Key Trial Info
Start Date :
July 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2026
Estimated Enrollment :
5391 Patients enrolled
Trial Details
Trial ID
NCT04894877
Start Date
July 1 2012
End Date
March 31 2026
Last Update
March 26 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.